NASDAQ: AYTU
Aytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?

Insider buying vs selling

Have Aytu Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jarrett DisbrowChief Business Officer2025-06-0916,666$1.50
$25.00kBuy
Joshua R. DisbrowChief Executive Officer2025-06-0966,666$1.50
$100.00kBuy
Joshua R. DisbrowChief Executive Officer2025-02-2815,000$1.30
$19.50kBuy

1 of 1

AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AYTU insiders and whales buy or sell their stock.

AYTU Shareholders

What type of owners hold Aytu Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC103.22%11,078,956$29.03MInsider
Cerecor Inc90.50%9,713,068$25.45MInsider
James B. Wiegand21.81%2,340,659$6.13MInsider
Ampio Pharmaceuticals Inc11.43%1,226,407$3.21MInsider
Christopher Brooke10.87%1,167,147$3.06MInsider
Nantahala Capital Management LLC10.13%1,086,812$2.85MInsider
Nantahala Capital Management LLC10.13%1,086,812$2.85MInstitution
Carl Dockery8.46%908,187$2.38MInsider
Stonepine Capital Management LLC8.31%891,855$2.34MInstitution
Awm Investment Company Inc5.77%619,574$1.62MInstitution

1 of 3

AYTU vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU10.78%89.22%Net Buying
TXMD3.61%96.39%Net BuyingNet Buying
APUS3.18%59.42%Net Buying
SCYX28.05%23.14%Net Buying
QNTM1.78%0.00%

Aytu Biopharma Stock Ownership FAQ

Who owns Aytu Biopharma?

Aytu Biopharma (NASDAQ: AYTU) is owned by 33.36% institutional shareholders, 275.98% Aytu Biopharma insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11.08M shares representing 103.22% of the company. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $26.04M.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.